Arthritis in HLA-B27 Transgenic Animals
- 1 October 1998
- journal article
- Published by Elsevier in The Lancet Healthy Longevity
- Vol. 316 (4) , 250-256
- https://doi.org/10.1097/00000441-199810000-00005
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Unraveling the mystery of HLA-B27 association with human spondyloarthropathies using transgenic and knock out miceSeminars in Immunology, 1998
- The pathogenetic role of HLA-B27 in chronic arthritisCurrent Opinion in Immunology, 1998
- A New MHC Locus That Influences Class I Peptide PresentationImmunity, 1997
- A new foreign policy: MHC class I molecules monitor the outside worldImmunology Today, 1996
- The Rat cim Effect: TAP Allele-Dependent Changes in a Class I MHC Anchor Motif and Evidence Against C-Terminal Trimming of Peptides in the ERImmunity, 1996
- HLA-B27 as a relative risk factor in ankylosing enthesopathy in transgenic miceHuman Immunology, 1995
- Advances in the use of embryonic stem cell technologyCurrent Opinion in Biotechnology, 1994
- Cross‐reactivity among evolutionarily distant major histocompatibility complex class I molecules (HLA‐B27 and H‐2Kk) revealed by xenoreactive T lymphocytesEuropean Journal of Immunology, 1993
- Strong xenogeneic HLA response in transgenic mice after introducing an α3 domain into HLA B27Nature, 1990
- Susceptibility of HLA-B27 transgenic mice to Yersinia enterocolitica infectionHuman Immunology, 1990